JB Chemicals bags ANDA approval for Midodrine Hydrochloride Tablet JB Chemicals bags ANDA approval for Midodrine Hydrochloride Tablet Bhagyashree Vivarekar / Monday, November 5, 2018 / Article rating: 5.0 JB Chemicals & Pharmaceuticals have received US FDA ANDA approval for their Midodrine Hydrochloride Tablets USP 2.5 mg, 5 mg and 10 mg. The same would be used for the treatment of orthostatic hypotension.
Quarterly Results to watch out on 6 November Quarterly Results to watch out on 6 November Shohini Nath / Monday, November 5, 2018 / Article rating: 2.5 The following stocks could be in focus in Tuesday’s trading session in light of their results: Graphite, Dr. Lal PathLabs, Manappuram Finance,Voltas and Cupid.
Lupin gets USFDA nod for Doxercalciferol Injection Lupin gets USFDA nod for Doxercalciferol Injection Shohini Nath / Monday, November 5, 2018 / Article rating: 5.0 Pharma major Lupin announced receiving the approval for its Doxercalciferol Injection, 4 mcg/2 mL (2 mcg/mL) multi-dose vials from USFDA.
Shivam Autotech reports net profit of Rs. 1.2 crore Shivam Autotech reports net profit of Rs. 1.2 crore Amir Shaikh / Monday, November 5, 2018 / Article rating: 2.7 The stock of Shivam Autotech opened today at Rs. 48.15 and touched intraday high of Rs. 50.40 per share. During Monday’s entire trading session the stock remained flat and closed at Rs. 49 apiece as against previous close of Rs. 48.90.
Overnight Digest: Stocks to watch out on November 6 Overnight Digest: Stocks to watch out on November 6 Dnyanada Kulkarni / Monday, November 5, 2018 / Article rating: 4.9 Stocks most likely to witness significant movement on the bourses on November 6 are Bosch, Lupin, Gulf Oil Lubricants, Exide Industries and GAIL.
Eveready Q2FY19 revenue down by 4.5 per cent YoY Eveready Q2FY19 revenue down by 4.5 per cent YoY Pratik Shastri / Monday, November 5, 2018 / Article rating: 5.0 Eveready Industries India Limited reported its results for the quarter ended September 30, 2018 during market hours on Monday. The standalone numbers were largely negative due to impact on top line as well as on the operational front.
NATCO Pharma reports 35 per cent YoY increase in revenues NATCO Pharma reports 35 per cent YoY increase in revenues Pratik Shastri / Monday, November 5, 2018 / Article rating: 5.0 NATCO Pharma Limited reported its results for the quarter ended September 30, 2018 during market hours on Monday.
Cipla reports 1 per cent YoY decline in revenue Cipla reports 1 per cent YoY decline in revenue Pratik Shastri / Monday, November 5, 2018 / Article rating: 5.0 Cipla Limited reported its results for the quarter ended September 30, 2018 during market hours on Monday.
Reliance Securities reports impressive Q2FY19 performance Reliance Securities reports impressive Q2FY19 performance Dnyanada Kulkarni / Monday, November 5, 2018 / Article rating: 5.0 Reliance Securities, the broking and distribution division of Reliance Capital, posted a positive financial performance for the quarter ended September, 2018.
GAIL reports 50 per cent rise in Q2 net profit GAIL reports 50 per cent rise in Q2 net profit Sanket Dewarkar / Monday, November 5, 2018 / Article rating: 5.0 The PAT for the quarter came in at Rs. 1,962.96 crore as against Rs. 1,309.63 crore in the corresponding quarter last year, yoy increase of 50 per cent.